The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis

Science. 1997 Feb 21;275(5303):1132-6. doi: 10.1126/science.275.5303.1132.

Abstract

In a cell-free apoptosis system, mitochondria spontaneously released cytochrome c, which activated DEVD-specific caspases, leading to fodrin cleavage and apoptotic nuclear morphology. Bcl-2 acted in situ on mitochondria to prevent the release of cytochrome c and thus caspase activation. During apoptosis in intact cells, cytochrome c translocation was similarly blocked by Bcl-2 but not by a caspase inhibitor, zVAD-fmk. In vitro, exogenous cytochrome c bypassed the inhibitory effect of Bcl-2. Cytochrome c release was unaccompanied by changes in mitochondrial membrane potential. Thus, Bcl-2 acts to inhibit cytochrome c translocation, thereby blocking caspase activation and the apoptotic process.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Amino Acid Chloromethyl Ketones / pharmacology
  • Animals
  • Apoptosis*
  • Carrier Proteins / metabolism
  • Cell Extracts
  • Cell-Free System
  • Cysteine Endopeptidases / metabolism
  • Cysteine Proteinase Inhibitors / pharmacology
  • Cytochrome c Group / metabolism*
  • Cytosol / metabolism
  • Membrane Potentials
  • Microfilament Proteins / metabolism
  • Mitochondria / metabolism*
  • Ovum
  • Proto-Oncogene Proteins c-bcl-2 / metabolism*
  • Proto-Oncogene Proteins c-bcl-2 / pharmacology
  • Recombinant Proteins
  • Xenopus

Substances

  • Amino Acid Chloromethyl Ketones
  • Carrier Proteins
  • Cell Extracts
  • Cysteine Proteinase Inhibitors
  • Cytochrome c Group
  • Microfilament Proteins
  • Proto-Oncogene Proteins c-bcl-2
  • Recombinant Proteins
  • benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone
  • fodrin
  • Cysteine Endopeptidases